Funding Opportunities

NIDDK Program Projects (P01) (PAR-16-127)
Description: This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated program project applications. The proposed programs should address scientific areas relevant to the NIDDK mission including diabetes, selected endocrine and metabolic diseases, obesity, digestive diseases and nutrition, and kidney, urologic and hematologic diseases, as well as new approaches to prevent, treat and cure these diseases, including clinical research.
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Dates(s): Multiple dates, see announcement.
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2) (PAR-16-126)
Description: The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The interdisciplinary approach encouraged by this FOA is envisioned to generate a community research resource for the broader community, which may include discovery-based or hypothesis-generating science. The interdisciplinary research team should be able to provide an integrative plan of working together to effectively address the complex challenge at hand. This program will support research projects that accelerate critical breakthroughs, early and applied research on cutting-edge technologies, and new approaches to improve the synergy and interactions among multi- and interdisciplinary research teams, including sharing of data and other resources to further advance research in this area. This FOA seeks novel approaches in areas that address specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that will advance the area in significant ways designed to accelerate scientific progress in the understanding, treatment and prevention of diseases within the mission of NIDDK.
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Dates(s): June 1, 2018; November 1, 2018, by 5:00 PM local time of applicant organization.
TACT2: Trial to Assess Chelation Therapy
Description: TACT2 follows up the positive results of TACT, an NIH-sponsored multicenter, double-blind efficacy trial; TACT2 is currently in a planning year funded by NCCIH; We are looking for trial sites to enroll, infuse and follow patients
Contact: For more information, contact the Study Chairman, Dr. Gervasio Lamas, at, @GLamasMD on Twitter, or (305) 674-2260.
PDF: TACT2 Trial Site Information.pdf

Please visit for a complete list of NIDDK funding opportunities.

Please visit for a complete list of active diabetes-related grants and funding from NIH.